{Etokimab: A Deep Investigation into the 2022981-44-6 Antibody Etokimab, designated by the unique identifier 2022981-44-6, represents a novel antibody currently in clinical evaluation. This biologic agent, targeting https://www.targetmol.com/compound/etokimab